Protocols

Apple’s ‘super secret’ plan to revolutionize diabetes care; Thiel’s Breakout Labs takes on 4 more startups

→ Just what is Apple up to? There have been several reports that the tech giant has a stealthy plan well under way to develop biosensors that can continually monitor the blood sugar of diabetics. That would mark a major achievement in the field, where the control of blood sugar through medication remains elusive for the one-third of patients who have been diagnosed but aren’t being treated properly.

→ Four more startups have been admitted into the ranks of Peter Thiel’s Breakout Labs. The group provides up to $350,000 to help these companies launch, reports MedCity News.

→ Cambridge, MA-based Wave Life Sciences has raised $93 million through the sale of shares.


The best place to read Endpoints News? In your inbox.

Comprehensive daily news report for those who discover, develop, and market drugs. Join 37,700+ biopharma pros who read Endpoints News by email every day.

Free Subscription

Biotech Investment Analyst
SV Health Investors Boston, MA
Director, Program Management
Contrafect Corporation New York, NY
Director, Translational Sciences
Cadent Therapeutics Cambridge, MA

Visit Endpoints Careers ->